IPO Central

Tatva Chintan Pharma Chem IPO description – Tatva Chintan Pharma Chem is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). The company is the largest and only commercial manufacturer of SDAs for zeolites in India while also enjoying the second largest position globally. In addition, the company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe.

The company’s products – 138 as of 31 December 2020 – are used across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from serving the domestic market, the company exports its products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. During the nine months ended 31 December 2020, exports of products accounted for 70.7% of its revenue from operations.

Promoters of Tatva Chintan Pharma – Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Shekhar Rasiklal Somani

IPO Opening Date: 16 July 2021
IPO Closing Date: 20 July 2021
Finalisation of Basis of Allotment: 26 July 2021
Initiation of refunds: 27 July 2021
Transfer of shares to demat accounts: 28 July 2021
Listing Date: 29 July 2021
Opening Price on NSE: INR2,111.85 per share (up 95% from IPO price)
Closing Price on NSE: INR2,312.2 per share (up 113.5% from IPO price)